These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 13639410)

  • 1. [In vitro antituberculous activity of the dihydrostreptomycin salt of sulfoniazid (streptorilone)].
    VIALLIER J; CAYRE RM
    C R Seances Soc Biol Fil; 1958; 152(11):1501-3. PubMed ID: 13639410
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radiological aspects of experimental tuberculosis in rabbits before and after treatment with dihydrostreptomycin, sulfoniazid and the neutral salts of streptomycin and dihydrostreptomycin with sulfoniazid].
    LUTZ A; SICHEL D
    J Belge Radiol; 1956; 39(3):323-38. PubMed ID: 13376540
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of combined action of dihydrostreptomycin, isoniazid, PAS and T40 on the growth of Mycobacterium tuberculosis in vitro].
    JANOWIEC M; KAMIENSKA I
    Gruzlica (1926); 1956 Jan; 24(1):15-22. PubMed ID: 13345079
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the antituberculous activity of 1-(2-butenylidene)-2-isonicotinoylhydrazine].
    VIALLIER J; OLLAGNIER C; AUGAGNEUR J
    C R Seances Soc Biol Fil; 1959; 153(1):109-10. PubMed ID: 13663369
    [No Abstract]   [Full Text] [Related]  

  • 5. [Variability of the polyresistance of the tubercle bacillus. I. Sensitivity to the paminosalicylic salt of isoniazid].
    VIALLIER J; CAYRE RM
    C R Seances Soc Biol Fil; 1958; 152(7):1127-9. PubMed ID: 13619195
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical evaluation studies in lepromatous leprosy second series: isoniazid and diasone (Diamidin) isoniazid and dihydrostreptomycin also a pilot study with streptohydrazid.
    DOULL JA; RODRIGUEZ JN; DAVISON AR; TOLENTINO JG; FERNANDEZ JV
    Int J Lepr; 1957; 25(3):173-92. PubMed ID: 13524990
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tuberculostatic activity of isonicotylamino-I, dimethyl-2,5, pyrrol (G.144), a structural analogue of isoniazid].
    GAZAVE JM; BUU-HOI NP; XUONG ND
    Therapie; 1957; 12(4):486-92. PubMed ID: 13467825
    [No Abstract]   [Full Text] [Related]  

  • 8. [In vitro and in vivo research on combined dihydrostreptomycin and isoniazid].
    DE CARNERI I; FACHINELLI E
    G Ital Chemioter; 1954; 1(3-4):561-4. PubMed ID: 14391670
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies in the field of salts and other synthetic derivatives of streptomycin and dihydrostreptomycin].
    Golubev VN
    Antibiotiki; 1967 Dec; 12(12):1119-29. PubMed ID: 4175283
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dihydrostreptomycin pantothenate & its tolerance in the treatment of pulmonary tuberculosis].
    VERAN P; BARON F; MOIGNETEAU C; TRICHEREAU R; DELHUMEAU G; BEAUPERE J
    Therapie; 1958; 13(2):220-6. PubMed ID: 13556698
    [No Abstract]   [Full Text] [Related]  

  • 11. [L-transformation of Mycobacterium tuberculosis strains isolated from patients treated with antibiotics].
    Kochemasova ZN; Dykhno MM; Prozorovskiĭ SV; Kassirskaia NG; Bakanova DIa
    Probl Tuberk; 1968; 46(8):64-7. PubMed ID: 4179328
    [No Abstract]   [Full Text] [Related]  

  • 12. [Search for new tuberculostatics. VI. Some newer derivatives of isoniazid].
    ZSOLNAI T
    Zentralbl Bakteriol Orig; 1959 Jun; 175(3-4):269-81. PubMed ID: 13669681
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental and clinical study of various recently discovered antibacillary substances; dihydrostreptomycin and cycloserine panthothenates].
    TACQUET A; VOISIN C; GERNEZRIEUX C
    Therapie; 1956; 11(6):1054-62. PubMed ID: 13409317
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental studies of anti-tuberculous effect of phthivaside].
    ZEBROWSKI T; PIENIAZEK J; TROJANOWSKI S; BOROWIECKA A
    Pol Tyg Lek (Wars); 1957 Sep; 12(36):1390-3. PubMed ID: 13505232
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanism of action & possibilities of application of isoniazid derivatives].
    IWAINSKY H; SIEGEL D
    Tuberkulosearzt; 1959 Feb; 13(2):116-22. PubMed ID: 13647677
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of extrapulmonary tuberculosis with didrothenate].
    REINHARD W; DUSBERG K
    Tuberkulosearzt; 1957 Feb; 11(2):93-6. PubMed ID: 13422650
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones.
    Sriram D; Yogeeswari P; Madhu K
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4502-5. PubMed ID: 16115763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis.
    Fattorini L; Gennaro R; Zanetti M; Tan D; Brunori L; Giannoni F; Pardini M; Orefici G
    Peptides; 2004 Jul; 25(7):1075-7. PubMed ID: 15245864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Technic of intravenous PAS-streptomycin-pantothenate treatment in tuberculosis].
    KUNTZ E
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1957; 117(2):259-64. PubMed ID: 13522541
    [No Abstract]   [Full Text] [Related]  

  • 20. 1H and 13C NMR characterization of pyridinium-type isoniazid-NAD adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis.
    Broussy S; Bernardes-Génisson V; Coppel Y; Quémard A; Bernadou J; Meunier B
    Org Biomol Chem; 2005 Feb; 3(4):670-3. PubMed ID: 15703806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.